comparemela.com

Latest Breaking News On - Application articles - Page 8 : comparemela.com

Streamline PCR and qPCR workflows

Explore how automation in liquid handling can transform the throughput, accuracy, and reliability of qPCR

Active & iterative data-dependent reinjection logic for maintaining throughput, uptime, and consistency in triple quadrupole LC/MS analysis

The 6475 triple quadrupole LC/MS system with MassHunter 12 features an intelligent workflow called iReflex, an intelligent automated worklist reinjection logic tool to maximise analytical throughput or ensuring samples are within tolerance.  In the application note, Agilent Technologies demonstrates three iReflex workflows, that can operate concurrently in one worklist to ensure samples are measured within SOP guidelines. 

An end-to-end software algorithm for LC/MS/MS method development, optimization, and QA/QC deployment

The new 6475 triple quadrupole LC/MS system with MassHunter 12 includes an intelligent MRM and source optimizer that is built into the method editor.  In this application note, Agilent Technologies demonstrates that this intelligent optimizer can be used to create a new method from scratch, add new components ton an existing method, and fine tune or verify parameters of an existing method. 

Accelerated lifetime testing with real-time Early Maintenance Feedback (EMF) diagnostic monitoring on the 6475 triple quadrupole LC/MS

To help alleviate concerns on instrument health and longevity, the new Agilent 6475 triple quadrupole LC/MS system was designed with onboard intelligence that actively reports on the instrument health and status through Early Maintenance Feedback (EMF).  In this application note, Agilent Technologies presents a use case to trigger EMF events to simulate heavy instrument use through 10,000 sample injections of spiked bovine urine. 

Evaluating immune cell therapy potency

This eBook from Agilent provides an overview of the current state of CAR T therapies, showcases the use of xCELLigence Real-Time Cell Analysis (RTCA) technology to evaluate the potency of novel adoptive cell therapies, and demonstrates how this technology can be incorporated into research and development as well as manufacturing workflows of cell therapies.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.